Keyword: PhRMA

HHS’ drug pricing plans are meant to signal to the healthcare industry—and voters—that it's serious on this issue, experts say. 

CMS wants drug companies to put their list prices in television ads, but whether that policy is something it can enforce remains a major question. 

The Trump administration is planning to force drug companies to include the list price of their products in direct-to-consumer advertising.

The drug industry continued its campaign to spread the blame for high prescription drug prices with its latest commissioned analysis.

The Trump administration is considering a proposal to overhaul safe harbor protections for pharmaceutical company rebates.

As the Trump administration takes aim at rising drug costs, healthcare organizations are weighing in on proposals from its plan to address the issue.

The GAO is calling for additional oversight of 340B hospitals and their contracted pharmacies.

A new coalition of industry giants says it will fight for "affordability" and "quality." But exact policy positions they support are still unknown.

There's plenty of work to be done in informing patients about precision medicine, according to a new survey.

The debate over the state of the 340B drug discount program continues to swirl.